Published in Am J Kidney Dis on February 01, 2000
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos Int (2004) 1.07
Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int (2003) 0.97
Management of mineral and bone disorder after kidney transplantation. Curr Opin Nephrol Hypertens (2012) 0.95
Vitamin D in organ transplantation. Osteoporos Int (2011) 0.78
Renale osteodystrophie. Wien Med Wochenschr (2013) 0.77
Effect of Vitamin D Receptor Activators on Glomerular Filtration Rate: A Meta-Analysis and Systematic Review. PLoS One (2016) 0.76
CKD-MBD after kidney transplantation. Pediatr Nephrol (2011) 0.75
Current evidence on vitamin D deficiency and kidney transplant: What's new? Rev Endocr Metab Disord (2017) 0.75
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther (1989) 4.18
Haemodialysis. Lancet (1999) 3.19
Low bone mineral density in adults with cystic fibrosis. Thorax (1999) 2.94
Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int (2001) 2.81
Peripheral skin necrosis complicating beta-blockage. Br Med J (1979) 2.54
Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int (1997) 2.47
Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med (1991) 2.42
Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans (2007) 2.36
Continuous ambulatory peritoneal dialysis: one year's experience in a UK dialysis unit. Br Med J (1980) 2.31
Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis. Lancet (1998) 2.30
Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies. Lancet (1982) 2.30
Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol (2002) 2.23
"Eosinophilic" peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol (1981) 2.14
The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest (1990) 2.12
Aluminium deposition in bone after contamination of drinking water supply. Lancet (1990) 2.08
Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia (1993) 2.05
Sarcomas in north west England: I. Histopathological peer review. Br J Cancer (1991) 1.95
The application of clinical guidelines for skull radiography in the Accident and Emergency department: theory and practice. Clin Radiol (1990) 1.90
Changes in vascular endothelium related to lymphocyte collections in diseased synovia. Arthritis Rheum (1983) 1.88
Detection and distribution of aluminium in bone. J Clin Pathol (1984) 1.85
Camelford water poisoning accident: serial neuropsychological assessments and further observations on bone aluminium. Hum Exp Toxicol (1993) 1.83
Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol (1992) 1.81
Matrix metalloproteinases: the clue to intervertebral disc degeneration? Spine (Phila Pa 1976) (1998) 1.78
Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxford) (2008) 1.75
Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours. Br J Cancer (2008) 1.74
Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum (2001) 1.71
The pharmacokinetics of single doses of metoclopramide in renal failure. Eur J Clin Pharmacol (1981) 1.65
Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone. Science (1977) 1.62
Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid. Perit Dial Int (1993) 1.58
Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int J Cancer (1997) 1.51
Identification of the A2 adenosine receptor binding subunit by photoaffinity crosslinking. Proc Natl Acad Sci U S A (1989) 1.50
Intraosseous thrombosis in ischemic necrosis of bone and osteoarthritis. Osteoarthritis Cartilage (1993) 1.49
Leiomyosarcoma with osteoclast-like giant cells. Histopathology (1992) 1.48
Acute carpal tunnel syndrome due to pseudogout. J Hand Surg Br (1992) 1.46
Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int (2000) 1.44
Functional and morphological changes in post-capillary venules in relation to lymphocytic infiltration into BCG-induced granulomata in rat skin. J Pathol (1985) 1.44
Monitoring of iron requirements in renal patients on erythropoietin. Nephrol Dial Transplant (1993) 1.43
Malignant pilomatrixoma with bone metastasis. Histopathology (1993) 1.43
Agonist derived molecular probes for A2 adenosine receptors. J Mol Recognit (1989) 1.43
Is long-term technique survival on continuous ambulatory peritoneal dialysis possible? Perit Dial Int (1997) 1.42
Limitations of the peritoneal equilibration test in prescribing and monitoring dialysis therapy. Nephrol Dial Transplant (1995) 1.42
Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors. Osteoarthritis Cartilage (2001) 1.42
Structural periodicity in human articular cartilage: comparison between magnetic resonance imaging and histological findings. Osteoarthritis Cartilage (1999) 1.41
Rare abnormalities of the scaphoid in association with congenital radial ray defects of the hand: a report of two cases. J Hand Surg Br (1991) 1.39
Rhabdomyosarcoma presenting as 'acute leukaemia'. Histopathology (1991) 1.38
Changes in numbers of epidermal cell adhesion molecules caused by oral cyclosporin in psoriasis. J Clin Pathol (1993) 1.38
Bone loss in celiac disease is related to secondary hyperparathyroidism. J Bone Miner Res (1999) 1.36
Continuous ambulatory peritoneal dialysis: three years' experience. Q J Med (1983) 1.33
Platelet-derived growth factor expression in normally healing human fractures. Bone (1995) 1.32
Jugular vein thrombosis associated with distant malignancy. Postgrad Med J (1988) 1.32
Pathologists and problem-based learning. J Pathol (1996) 1.32
Distribution of type X collagen mRNA in normal and osteoarthritic human cartilage. Bone Miner (1991) 1.31
Intervertebral foramen venous obstruction. A cause of periradicular fibrosis? Spine (Phila Pa 1976) (1989) 1.29
Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload. Q J Med (1979) 1.28
A molecular characterization of Clostridium difficile isolates from humans, animals and their environments. Epidemiol Infect (1993) 1.28
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis. Osteoporos Int (2011) 1.28
Vertebral shape: automatic measurement with active shape models. Radiology (1999) 1.27
Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis. Perit Dial Int (1993) 1.26
Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children. Bone (2005) 1.25
Human disc degeneration is associated with increased MMP 7 expression. Biotech Histochem (2006) 1.25
Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. Br J Ophthalmol (1989) 1.24
Radiographic features of lumbar disc degeneration and bone mineral density in men and women. Ann Rheum Dis (2005) 1.22
The role of inflammation in disk herniation-associated radiculopathy. Semin Arthritis Rheum (1998) 1.20
Acid esterase activity in lymphocytes and other cells: a comparison of six alpha-naphthyl based substrates. Med Lab Sci (1982) 1.20
Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int (2012) 1.19
A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years. Eur Respir J (1999) 1.19
The pathogenesis of degeneration of the intervertebral disc and emerging therapies in the management of back pain. J Bone Joint Surg Br (2012) 1.19
Intervertebral disc biology, degeneration and novel tissue engineering and regenerative medicine therapies. Histol Histopathol (2007) 1.18
A randomized, controlled trial of vitamin D supplementation upon musculoskeletal health in postmenarchal females. J Clin Endocrinol Metab (2010) 1.18
Chronic thalamic stimulation for the control of facial anesthesia dolorosa. Arch Neurol (1973) 1.18
The scenario paper: an integrated examination for an integrated course. J Pathol (1996) 1.17
Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin Exp Immunol (2000) 1.16
Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care (1995) 1.16
Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease. Diabet Med (2002) 1.16
Recommendations for thresholds for cortical bone geometry and density measurement by peripheral quantitative computed tomography. Calcif Tissue Int (2005) 1.15
Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol (1994) 1.15
Light microscopic, histochemical and ultrastructural studies of human lymph node paracortical venules. J Anat (1983) 1.14
Disease distribution of synovial fluid mast cells and cytophagocytic mononuclear cells in inflammatory arthritis. Ann Rheum Dis (1985) 1.14
Peritonitis in continuous ambulatory peritoneal dialysis. J Antimicrob Chemother (1982) 1.14
Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin Exp Immunol (1999) 1.14
Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects. Clin Endocrinol (Oxf) (1997) 1.14
Bone abnormalities and severe arthritis in pachydermoperiostosis. Ann Rheum Dis (1992) 1.13
A prospective study of change in bone mineral density over one year in adults with cystic fibrosis. Thorax (2002) 1.13
Imaging of trabecular bone structure in osteoporosis. Eur Radiol (1999) 1.12
Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease. J Bone Miner Res (1994) 1.11
The empty sella syndrome. J Neurosurg (1968) 1.10
Mandibular bone mineral density as a predictor of skeletal osteoporosis. Br J Radiol (1996) 1.10
Sarcomas in north west England: II. Incidence. Br J Cancer (1991) 1.09
Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation. Ann Rheum Dis (1994) 1.09
Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases. Ann Rheum Dis (1989) 1.08
Gastrointestinal carriage of Clostridium difficile in cats and dogs attending veterinary clinics. Epidemiol Infect (1991) 1.08
Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab (1994) 1.08
Mobility status and bone density in cerebral palsy. Arch Dis Child (1996) 1.08
A possible route for lymphocyte migration into diseased tissues. J Clin Pathol (1983) 1.08
Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab (1993) 1.08
Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int (1998) 1.07